StepStone Group LP

Holdings History for Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Symbol: TRDA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	4.5%	0%	$7,825,928	761,277	0		$10.28	Q4 2025
30 Sep 2025	2.2%	0%	$4,415,407	761,277	0		$5.80	Q3 2025
30 Jun 2025	10%	0%	$5,115,781	761,277	0		$6.72	Q2 2025
31 Mar 2025	7.1%	0%	$6,881,944	761,277	0		$9.04	Q1 2025
31 Dec 2024	12%	0%	$13,162,479	761,277	0		$17.29	Q4 2024
30 Sep 2024	4.4%	0%	$12,165,207	761,277	0		$15.98	Q3 2024
30 Jun 2024	2.2%	0%	$10,848,197	761,277	0		$14.25	Q2 2024
31 Mar 2024	2.3%	0%	$10,787,295	761,277	0		$14.17	Q1 2024
31 Dec 2023	2.1%	0%	$11,487,670	761,277	0		$15.09	Q4 2023
30 Sep 2023	2.9%	0%	$12,028,177	761,277	0		$15.80	Q3 2023
30 Jun 2023	2.1%	0%	$11,525,734	761,277	0		$15.14	Q2 2023
31 Mar 2023	2.1%	0%	$11,038,517	761,277	0		$14.50	Q1 2023
31 Dec 2022	1.3%	0%	$10,292,465	761,277	0		$13.52	Q4 2022
30 Sep 2022	1.7%	+0.28%	$11,998,000	761,277	+126,318	+20%	$15.76	Q3 2022
30 Jun 2022	0.83%	-0.16%	$7,734,000	634,959	-126,318	-17%	$12.18	Q2 2022
31 Mar 2022	0.57%	0%	$7,148,000	761,277	0		$9.39	Q1 2022
31 Dec 2021	0.75%	+0.75%	$13,033,000	761,277	+761,277	NEW	$17.12	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.